Global Research, June 28, 2022
Corona Investigative Committee 25 June 2022
All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
To receive Global Research’s Daily Newsletter (selected articles), click here.
Guest: Karen Kingston – Biotech Analyst and med-legal advisor with over 20 years of experience driving blockbuster commercialization efforts for medical devices and prescription therapies. Owner of Varitage Strategies (since 2014). Was once a Cardiovascular Sales Representative for the Northeast Region (NY) at Pfizer.
This session is about:
- an Infants and Toddlers study by Pfizer:
“It is statistically and clinically impossible to conduct a clinical trial that will prove a vaccine will be more effective than a child’s natural immune system.“
- BLA/FDA approval (not shielded by EUA research)
- new insights into the 2-SP Spike:
“It’s a weaponized trimerized prefusion spike with 2 Proline modifications, aka optimized codons in Comirnaty and all other COVID-19 shots”
- About the Operation Warp Speed contracts, especially the DoD/Pfizer contract
Note to readers: Please click the share buttons above or below. Follow us on Instagram, Twitter and Facebook. Feel free to repost and share widely Global Research articles.
Featured image is a screenshot from the video
The original source of this article is Corona Investigative Committee